Biochemical screening for congenital defects
Authors:
- Ray O. Bahado-SinghRBRay O. Bahado-Singh
- Jaime Sutton-RileyJSJaime Sutton-Riley
- 1 December 2004
- journal article
- review article
- Published by Elsevier in Obstetrics and Gynecology Clinics of North America
- Vol. 31 (4) , 857-872
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Integrating antenatal Downʼs syndrome screeningCurrent Opinion in Obstetrics and Gynecology, 2001
- COMBINING INHIBIN A WITH EXISTING SECOND-TRIMESTER MARKERS IN MATERNAL SERUM SCREENING FOR DOWN'S SYNDROMEPrenatal Diagnosis, 1996
- Risk‐based prenatal screening for trisomy 18 using alpha‐fetoprotein, unconjugated oestriol and human chorionic gonadotropinPrenatal Diagnosis, 1995
- A new simple and rapid dual assay for AFP and free β hCG in screening for Down syndromeClinical Genetics, 1994
- A comparison of total and free β‐HCG assays in Down syndrome screeningPrenatal Diagnosis, 1993
- Second-trimester cancer antigen 125 and Down's syndromePrenatal Diagnosis, 1992
- Improved performance in a prenatal screening programme for Down's syndrome incorporating serum‐free hCG subunit analysesPrenatal Diagnosis, 1992
- FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROMEThe Lancet, 1988
- Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndromeBJOG: An International Journal of Obstetrics & Gynaecology, 1988
- AFP SCREENING AND DOWN SYNDROMEThe Lancet, 1985